Tachycardia, unexplained weight loss, tremor, excessive diaphoresis, or a significantly elevated resting heart rate during or after exercise should be noted and communicated to the medical team, as they may indicate a need to adjust the dose
Storage: keep in a cool, dry, dark environment
The sequential approach The ATTAIN-MAINTAIN trial introduces a compelling treatment strategy: using tirzepatide and orforglipron sequentially rather than choosing one or the other
Any decision to use bupropion and Saxenda together must be made under the direct supervision of a qualified healthcare professional who can assess the individual risk-benefit profile and provide appropriate clinical oversight throughout treatment
While GLP-1 medications are incredibly effective for reducing body fat, they cannot tighten skin, rebuild collagen, restore facial support, or contour the body after major volume loss